Graded nomograms based on perioperative parameters for predicting New-Onset severe acute kidney injury following liver transplantation in patients with normal preoperative renal function: the SALT scale

基于围手术期参数的分级列线图,用于预测术前肾功能正常的肝移植患者术后新发严重急性肾损伤:SALT 评分

阅读:1

Abstract

This study aimed to develop a predictive model and construct a graded nomogram to estimate the risk of severe acute kidney injury (AKI) in patients without preexisting kidney dysfunction undergoing liver transplantation (LT). Patients undergoing LT between January 2022 and June 2023 were prospectively screened. Severe AKI was defined as Kidney Disease: Improving Global Outcomes stage 3. Using the least absolute shrinkage and selection operator (LASSO) analytics, we identified the preoperative, intraoperative, and postoperative factors associated with severe AKI. Machine learning were employed to develop predictive models, and the most suitable model was selected for further analysis. The Shapley Additive Explanation was utilized to construct graded nomograms, forming the Severe AKI post-LT (SALT) scale. Among the 405 patients, 44 had AKI stage 3 (severe AKI). The Model for End-Stage Liver Disease (MELD) score, estimated blood loss, alanine aminotransferase, D-dimer, and thromboelastography reaction time within 24 h post-LT were identified as risk factors. The logistic regression model achieved the highest area under the receiver operating characteristic curve (AUROC) of 0.885. The graded SALT scale, based on the logistic regression model, achieved AUROCs of 0.751, 0.826, and 0.894. The AUROCs for the testing cohort is 0.791. This preliminary study provides a SALT scale for assessing the occurrence of severe AKI after LT. Although additional data are needed to externally validate our model before applying it to patient care, our findings suggest that the SALT scale may be a feasible bedside tool for assessing the risk of AKI after LT.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。